Homerobotics

robotics

Stay Connected
- Advertisement -spot_img
Latest Articles

ALS data revealed at Neuroscience 2026

Axoltis Pharma has announced additional data and analyses from SEALS, its phase 2 clinical trial evaluating NX210c in patients with amyotrophic lateral sclerosis (ALS),...